Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.